Biodesix, Inc.
BDSX
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $214.5M
$25.69
▼ -2.50%
P/E
-8.13
Mkt Cap
$214.5M
52-Wk Range
$5.26–$31.31
52-Week Range
$5.26 - $31.31
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 203.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary blood-based diagnostic technology reducing need for invasive procedures
- Clinical validation and regulatory approvals for multiple test panels
- Strategic partnerships with established diagnostics companies (Bio-Rad Laboratories)
- Comprehensive data platform integrating genomic and immunological insights
Bear Case
1 risk
- Low volatility (beta 0.6).
Growth
Stable outlook
Increasing adoption of precision medicine and early cancer detection protocols
Value
Deep value opportunity - significant discount to Life Sciences Tools peers
Momentum
Hot
+72.5% over 3m
Quality
Excellent
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying BDSX right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 5, 2026
Reported EPS of -$0.71 vs -$0.90 consensus (+21.3% surprise). Revenue of $26.9M vs $26.0M expected (+3.2%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+21.3%
Revenue trend · last 8Q
—
—
+21%
+12%
+20%
+41%
+42%
+34%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$18.2M
$20.4M
$18.0M
$20.0M
$21.8M
$28.8M
$25.6M
$26.9M
Margins · last 8Q
Gross
-79.5%
Operating
-20.1%
Profit
-27.1%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Aug 6, 2026
vs Industry
How BDSX stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related